The latest edition of the Lung-MAP newsletter is now available for our clinical trial sites.

Get the news on our latest sub-study, and tissue specification information here.

You can also get more information about Lung-MAP, a lung cancer precision medicine trial, at the trial website.

Lung-MAP tests new treatments for advanced non-small cell lung cancers, and is supported by a unique public-private partnership that includes the National Cancer Institute, the Foundation for the National Institutes of Health, Friends of Cancer Research, and the SWOG Cancer Research Network.

Other Recent Stories